NanoActive® Phyto-Retinal Booster
The Ultimate Synergy of Retinaldehyde and Silymarin: Pioneering Advanced Bioretinoid Therapy
Manufacturer: PuriPharm Co. Ltd.
Product Category: High-efficacy Functional Actives (PuriActives®) / Advanced Nano Delivery Systems (NanoActive®)
INCI Name: Water, Glycerin, Phospholipids, Retinal, Silybum Marianum (Milk Thistle) Extract, Caprylic/Capric Triglyceride
1. Product Concept: Solving the “Retinoid Paradox”
In the landscape of dermatology, Retinoids remain the gold standard for age-reversal. However, the industry has long been hindered by the “Retinoid Paradox”—the inverse relationship between biological potency and skin tolerance.
- The Demand for High-Potency Anti-Aging: Traditional Retinol requires two metabolic oxidation steps to become active, often leading to “Retinoid Dermatitis” (peeling, erythema) at effective concentrations.
- The Sensitive Skin Frontier: There is a critical market need for a solution that provides deep dermal restructuring without compromising the integrity of the epidermal barrier.
NanoActive® Phyto-Retinal Booster overcomes these challenges by integrating Retinaldehyde (the one-step precursor to Retinoic Acid) with Silymarin (a natural bio-shield) within a proprietary nano-encapsulation matrix. This is not merely a combination of ingredients, but a fundamental reconfiguration of skin pharmacokinetics.
2. Bio-Actives & Molecular Mechanisms
I. Retinaldehyde (Retinal): The “One-Step” Metabolic Pathway
Retinaldehyde is the direct precursor to Retinoic Acid. By bypassing the slow, rate-limiting oxidation step required by Retinol, it delivers superior performance:
- Metabolic Efficiency: Retinal is converted into active Retinoic Acid up to 11 times more efficiently than Retinol within skin cells.
- Targeted Remodeling: It actively triggers fibroblasts to up-regulate Collagen Type I, Type III, and Elastin, significantly strengthening the Dermo-Epidermal Junction (DEJ).
II. Silymarin: The Phyto-Shield against Inflammaging
Silymarin acts as both a biological buffer and a potent anti-aging active in its own right:
- Inhibiting Inflammaging: By precisely inhibiting the NF-κB signaling pathway, Silymarin blocks the release of pro-inflammatory cytokines, fundamentally mitigating the risk of “Retinoid-induced” irritation.
- Molecular Stabilization: Its robust radical scavenging capacity neutralizes UV-induced ROS, shielding the sensitive Retinal molecule from photodegradation.
3. NanoActive® Advanced Delivery System
Utilizing biomimetic phospholipid bilayer technology, PuriPharm encapsulates these actives into ultra-fine vesicles (~10-100nm) for “Smarter Delivery”:
- Superior Permeation: The extremely small particle size (~50nm average) allows the vesicles to navigate the intercellular lipid matrix, reaching the basal layer and upper dermis with ease.
- Controlled Release & Bioavailability: By mimicking the skin’s natural cell membranes, the system ensures high compatibility and a sustained release profile, preventing the “concentration spikes” that cause acute irritation.
- Chemical Shielding: Provides a physical barrier against oxygen and UV radiation, dramatically extending the shelf-life and efficacy of the Retinal molecule in final formulations.
4. Technical Advantages & Formulation Guidelines
- Water-soluble: Unlike conventional hydrophobic Retinal, this system is fully water-dispersible, allowing for the creation of high-performance serums, lightweight night creams, and even transparent formulations.
- Enhanced Safety Profile: Clinical evaluations demonstrate a reduction in irritation scores by over 60% compared to free Retinol at equivalent biological activity levels.
- Color & Stability: Yellow to brownish-yellow viscous liquid. Our stabilization technology prevents the severe browning/yellowing issues common with traditional Retinal powders.
5. Efficacy Data: From Science to Results
- Cellular Regeneration: +45% increase in Keratinocyte proliferation within 72 hours (in-vitro).
- Genetic Up-regulation: mRNA expression for Collagen Type I and III increased by over +120%.
- Clinical Efficacy: 28-day in-vivo studies show significant reduction in wrinkle depth and visible improvements in skin density and luminosity.
6. Application Guidelines
- Recommended Dosage: 1.0% – 5.0%
- Optimal pH Range: 4.5 – 6.5 (Aligns with skin’s natural acidity while maximizing carrier stability).
- Processing: Cold process highly recommended; add at the end of the manufacturing cycle.
PuriPharm Co. Ltd. (浦瑞生物医药技术有限公司)
Leading Advanced Nano Delivery: Transforming Molecular Science into Exceptional Efficacy.
ACTIVE SCIENCE. ADVANCED DELIVERY. REAL IMPACT.
From Science to Results.
Contact: service@puripharm.com
NanoActive 4-TERPINEOL: The Pure Power of Tea Tree, Delivered with Nano-Precision
1. Product Overview
NanoActive 4-TERPINEOL is a highly purified, nanostructured lipid carrier (NLC) encapsulated formulation of 4-Terpineol, the most potent and functional active ingredient naturally found in Melaleuca alternifolia (Tea Tree) oil.
By isolating the highly active 4-Terpineol and utilizing PuriPharm’s proprietary NanoActive™ Delivery Technology, we have created a next-generation active ingredient. It offers exceptional broad-spectrum antimicrobial and anti-inflammatory properties while completely bypassing the classical limitations of traditional essential oils, such as poor water solubility, high volatility, pungent odor, and skin sensitization.
INCI Name: 4-Terpineol, Phospholipids, Glycerin, Water
Appearance: Opalescent to translucent liquid
Recommended Usage: 1.0% – 5.0%
2. The Challenge & The PuriPharm Solution
The Limits of Conventional 4-Terpineol
While 4-Terpineol is scientifically proven to be vastly superior to whole Tea Tree Oil in targeting Cutibacterium acnes and Demodex mites, its use in cosmetic formulations has been severely hindered:
- Formulation Incompatibility: Highly lipophilic and totally insoluble in water.
- Sensory Issues: Strong, characteristic medicinal odor that is difficult to mask.
- Instability: Prone to volatilization and oxidation during storage.
- Irritation: High concentrations can compromise the skin barrier and cause erythema.
The NanoActive™ Breakthrough
PuriPharm has engineered a sub-micron encapsulation system (particle size: 10nm – 100nm). The active 4-Terpineol is safely enclosed within a biocompatible phospholipid bilayer.
- Total Water Solubility: Transforms a highly lipophilic compound into an easily dispersible, clear aqueous system.
- Odor Masking: The lipid encapsulation significantly reduces the characteristic terpene odor, allowing for elegant, fragrance-free formulations.
- Targeted Follicular Delivery: The lipophilic nature of the nanocarrier ensures targeted accumulation in the pilosebaceous unit, precisely where C. acnes and sebum reside.
- Sustained Release & Zero Irritation: Controlled release kinetics prevent immediate spikes in local concentration, minimizing irritation and extending efficacy.
3. Mechanism of Action & Efficacy
A. Broad-Spectrum Antimicrobial & Anti-Parasitic Activity
NanoActive 4-TERPINEOL acts directly on the microbial cell membrane, disrupting its integrity without inducing bacterial resistance.
- Acne Management: Exhibits a remarkably low Minimum Inhibitory Concentration (MIC) against Cutibacterium acnes and Staphylococcus aureus.
- Scalp & Dandruff: Highly effective against Malassezia furfur, balancing the scalp microbiome.
- Rosacea & Demodex: A proven, potent agent for paralyzing and eradicating Demodex folliculorum (face mites), a key trigger for rosacea and adult acne.
B. Immunomodulation & Inflammation Reduction
Beyond microbial control, 4-Terpineol actively suppresses the production of pro-inflammatory mediators. It inhibits the release of cytokines such as TNF-α, IL-1β, IL-8, and PGE2 from activated monocytes, rapidly reducing the clinical signs of inflammation, erythema, and swelling associated with acne lesions.
4. Cosmetic Applications
NanoActive 4-TERPINEOL is a versatile, high-performance active suitable for a wide range of dermatological and personal care applications:
- Anti-Acne & Blemish Control: Serums, spot treatments, and purifying toners.
- Sensitive Skin & Rosacea Care: Soothing lotions and barrier-repair creams.
- Advanced Scalp Care: Anti-dandruff shampoos and scalp-purifying treatments.
- Intimate Care: Gentle, pH-balanced washes for microbiome control.
- Men’s Grooming: Aftershave balms to prevent folliculitis.
5. Formulation Guidelines
PuriPharm guarantees ease of use for formulators:
- Solubility: Readily dispersible in water and cold-processable.
- Process: Can be added directly to the aqueous phase or at the end of the formulation process (<45°C).
- pH Stability: Stable across a broad pH range (4.0 – 7.0).
- Compatibility: Highly compatible with standard cosmetic ingredients, including AHA/BHAs, niacinamide, and typical rheology modifiers.
PuriPharm Co. Ltd. Innovating the Future of Active Delivery.
NanoActive® BAKUCHIOL SALICYLATE: The Next-Gen Retinoid-Alternative for Dual-Action Care
Introduction
As the dermo-cosmetic market shifts towards high-efficacy yet low-irritation solutions, the demand for “Retinol-like” performance without the associated “Retinol burn” has reached a peak. NanoActive® BAKUCHIOL SALICYLATE is a technologically advanced active that bridges the gap between anti-aging and blemish control.
By combining the terpenoid structure of Bakuchiol with the exfoliating and anti-inflammatory properties of Salicylic Acid, and subsequently encapsulating this conjugate within a biomimetic Nano-Delivery System (NDS), we offer a multi-dimensional tool for modern skincare. This system overcomes the inherent hydrophobic nature of the actives, providing a crystal-clear, water-soluble solution that penetrates deeply to reset cellular behavior.
The Technology: Synergistic Molecular Architecture
1. Molecular Functionalization
Unlike simple physical blends, NanoActive® BAKUCHIOL SALICYLATE leverages a synergistic approach where the anti-aging signaling of Bakuchiol and the keratolytic action of Salicylic Acid work in tandem. This conjugation maximizes the inhibition of pro-inflammatory cytokines while stimulating dermal matrix synthesis.
2. Nano-Encapsulation (NDS)
The active is embedded in a phospholipid-based nanosphere (average size < 100 nm). This provides:
- Superior Stability: Prevents photo-oxidation and degradation.
- Enhanced Bioavailability: Significant increase in transdermal flux compared to free-form Bakuchiol.
- Non-Irritating Profile: Slow-release mechanism reduces the acute irritation often associated with salicylic acid, making it suitable for sensitive skin.
Biological Mechanisms & Efficacy
1. Dermal Matrix Restructuring
NanoActive® BAKUCHIOL SALICYLATE acts on the same gene pathways as Retinoids, upregulating Type I Collagen (COL1A1) and Type III Collagen, while suppressing the activity of MMP-1 to prevent collagen breakdown. It effectively reduces fine lines and improves skin elasticity.
2. Targeted Blemish Control & Pore Refinement
The salicylic acid moiety provides precise keratolytic action, clearing follicular debris. Simultaneously, the Bakuchiol component regulates sebum composition and inhibits the proliferation of Cutibacterium acnes, making it the ideal solution for adult acne and “maskne.”
3. Anti-Inflammatory & Soothing
By inhibiting the NF-κB signaling pathway, it calms chronic micro-inflammation (Inflamm-aging), reducing erythema and post-inflammatory hyperpigmentation (PIH).
Technical Specifications
Strategic Applications
- Retinol-Alternative Elixirs: For consumers seeking ageless skin without the downtime of retinoids.
- Blemish & Age Intercept Serums: Specifically designed for adult acne and skin texture refinement.
- Glass Skin Foundations: Incorporating treatment benefits into high-clarity aqueous makeup bases.
- Post-Procedure Recovery: To soothe and prevent pigmentation in sensitive skin types.
Disclaimer: This document is intended for B2B purposes only. All claims must be verified by the final formulator in accordance with regional cosmetic regulations.
Pioneering the Future of Skincare Efficacy
At PuriPharm, we bridge the gap between advanced biomedical science and transformative cosmetic solutions. As a leading innovator in active ingredients and delivery architectures, we empower global personal care brands to achieve unprecedented clinical efficacy. Our core philosophy is built on two pillars: extracting the absolute potential of bioactive molecules, and ensuring their precise delivery to the target site.
Our Core Technology Matrix
PuriPharm’s innovation engine is driven by two flagship platforms, designed to work independently or in powerful synergy to elevate your formulations.
1. PuriActives®: The Pinnacle of Biological Efficacy
PuriActives® represents our premier line of highly purified, biologically active compounds. Rooted in synthetic biology, advanced fermentation, and precision extraction technologies, the PuriActives® portfolio delivers potent, mechanism-driven ingredients.
- Uncompromised Purity: Rigorous isolation processes ensure that only the most active molecules are retained, minimizing impurities and maximizing safety.
- Mechanism-Driven: Each active is developed with a clear understanding of cellular pathways, offering targeted solutions for anti-aging, pigmentation control, skin barrier repair, and microbiome balance.
- Sustainable Sourcing: Inspired by nature and optimized in the lab, we minimize ecological impact while delivering consistent, scalable results.
Key Applications: Bio-mimetic Peptides, Recombinant Proteins, High-purity Botanical Extracts.
2. NanoActive®: Precision Delivery, Amplified Performance
The most potent active ingredient is only as effective as its ability to reach its target. NanoActive® is our proprietary, state-of-the-art nanotechnology delivery platform, engineered to overcome the thermodynamic and physiological barriers of the stratum corneum.
- Enhanced Bioavailability: Utilizing advanced liposomal, solid lipid nanoparticle (SLN), and nano-emulsion architectures, NanoActive® dramatically increases the solubility and skin penetration of challenging active molecules.
- Controlled & Sustained Release: Our carrier systems are designed for spatio-temporal precision, releasing the actives gradually to ensure long-lasting efficacy and lower irritation profiles.
- Formulation Stability: By encapsulating sensitive compounds (e.g., Retinol, Vitamin C, Resveratrol), NanoActive® shields them from oxidation, light, and formulation incompatibilities, extending product shelf life.
The Science of Delivery: Nanostructured Lipid Carriers (NLC), Multi-lamellar Liposomes, Micro-sponges.
The Synergy of Science and Business
At PuriPharm, we do more than supply ingredients; we provide architectural solutions for your formulations. Whether you require the potent biological triggers of PuriActives® or the sophisticated delivery mechanisms of NanoActive®—or a customized integration of both—our team of scientists and market experts is ready to co-create your next hero product.
PuriPharm Co. Ltd. Innovating Molecules. Architecting Delivery. Transforming Beauty.
NanoActive® BAICALIN
A New Era in Telomerase-Targeted Anti-Aging: Ultimate Repair at the Cellular Core
PURIPHARM: PIONEERS IN DELIVERY INNOVATION
Leading the “Transdermal Delivery” Revolution
PuriPharm is dedicated to the efficient delivery of biological active ingredients. The NanoActive® platform, driven by our proprietary NDS (Nano Delivery System) technology, overcomes the traditional limitations of active compounds regarding stability, solubility, and permeability.
Focus on nano-encapsulation of bioactives.
Pharmaceutical-grade R&D and manufacturing standards.
Empowering premium global cosmetic brands.
BAICALIN: NATURE’S “LONGEVITY FACTOR”
Modern Science from Traditional Medicine
Extracted from the roots of Scutellaria baicalensis, Baicalin is widely recognized in dermatology as a highly potent, multi-functional active ingredient. Extensive SCI research confirms its superior performance in delaying cellular senescence, neutralizing free radicals, and repairing UV damage.
Key Profile: A high-purity flavonoid compound and a natural telomerase activator.
TRADITIONAL CHALLENGES: FORMULATION BOTTLENECKS
THE NANOACTIVE® SOLUTION
Driven by Molecular Motor Technology
NanoActive® BAICALIN utilizes ATP synthase molecular motor technology to encapsulate active molecules within biological microcapsules that highly simulate cellular membrane structures.
Particle Size: 10-100nm, increasing transdermal delivery by 500%.
Stability: Enhances anti-oxidative degradation capacity by more than 10 times.
Solubility: 100% highly water-soluble for crystal-clear formulations.
Core Mechanism: Molecular Targeted Repair
TELOMERASE: THE “BIOLOGICAL CLOCK”
Breaking the Hayflick Limit
Telomeres are protective caps located at the ends of chromosomes that shorten with each cell division. Once telomeres are depleted, the cell enters a state of irreversible “Senescence”.
Telomerase is the only crucial enzyme capable of replenishing telomere length and resetting cellular lifespan. Baicalin is proven to be one of the very few natural small molecules capable of effectively activating this enzyme.
CORE MECHANISM: ACTIVATING HTERT EXPRESSION
DEFENDING AGAINST PHOTOAGING: UVA/UVB PROTECTION
MOLECULAR TARGETS: REGULATING P53/P16 SIGNALING
IN VITRO: SIGNIFICANT ROS SCAVENGING
IN VITRO: PROMOTING FIBROBLAST PROLIFERATION
IN VITRO: DNA DAMAGE REPAIR (Γ-H2AX)
Clinical Research: Efficacy Validation
CLINICAL: MULTI-DIMENSIONAL WRINKLE REDUCTION
CLINICAL: ENHANCING ELASTICITY & FIRMNESS
CLINICAL: IMPROVING TEXTURE & REFINEMENT
COMPARISON: NANOACTIVE® VS TRADITIONAL
FORMULATION GUIDELINES: STABILITY & COMPATIBILITY
SAFETY & COMPLIANCE: RIGOROUS STANDARDS
Redefining High-End Anti-Aging Actives
NanoActive® BAICALIN is more than just an antioxidant; it is a molecular bridge across the Hayflick limit. Through precise targeting of telomerase, we enable skin cells to recapture the metabolic vitality of their youth.
NanoActive® BAICALIN: The Intelligent “Telomerase” Activator for Cellular Youth
Unleashing Baicalin’s Cellular Anti-Aging Potential through Advanced Nano-Targeted Delivery
1. Discovering Nature’s Time Code: Baicalin & The Delivery Bottleneck
Scutellaria baicalensis Georgi has long been revered as a “Golden Herb” in traditional Eastern medicine. Its core polyphenolic flavonoid active—Baicalin—has been extensively validated by top-tier SCI journals (e.g., Journal of Investigative Dermatology, Free Radical Biology and Medicine) for its outstanding pharmacological properties, including ROS scavenging, MMPs inhibition, and broad-spectrum UV protection.
However, in modern dermatology and premium cosmetic applications, unmodified Baicalin faces a notoriously difficult translational gap: stellarin vitrodata, but mediocrein vivoefficacy. This is driven by three critical challenges:
- High Crystallinity & Poor Solubility: Highly prone to crystallization and precipitation in cosmetic emulsions or serums, making it impossible to maintain at high free-state concentrations.
- Extreme Physicochemical Instability: Containing multiple oxidation-prone phenolic hydroxyl groups, it easily browns and develops off-odors when exposed to light, heat, or mildly alkaline formulations.
- Extremely Low Bioavailability: Its large molecular polarity means it is heavily blocked by the dense “brick-and-mortar” structure of the Stratum Corneum, failing to penetrate into the dermis to exert gene-level targeted effects.
PuriPharm: The NanoActive® Targeted Intelligent Delivery Solution
Fusing biomimetic medicine with nanofluidic dynamics, PuriPharm utilizes its proprietary NanoActive® encapsulation technology. We have constructed Multilamellar Vesicles that highly mimic the structure of human cell membranes, precisely and stably embedding high-purity Baicalin within an amphiphilic nano-bilayer structure.
This breakthrough technology completely dismantles Baicalin’s physical barriers, achieving a systemic quadruple leap: High Solubility, Supreme Stability, Targeted Deep Penetration, and Prolonged Sustained Release.
2. Core Mechanism of Action (MoA): Targeting the Root of Cellular Senescence
Leveraging the highly efficient transmembrane fusion capabilities of the NanoActive® carrier, Baicalin can reach efficacious therapeutic concentrations inside living cells, exerting critical regulatory roles across three cutting-edge anti-aging pathways:
2.1 Targeted Telomerase Activation, Guarding the DNA Terminal Lifeline
Nobel Prize-winning research indicates that replicative cellular senescence is dictated by the “biological clocks” at the ends of chromosomes—Telomeres. UV irradiation and chronic oxidative stress dramatically accelerate telomere shortening, leading to irreversible cellular senescence.
- Upregulation of TERT Genes: NanoActive® BAICALIN penetrates deep into the nucleus to specifically activate or maintain the expression levels of Telomerase Reverse Transcriptase (TERT).
- Rescuing G1 Phase Arrest: It significantly downregulates core senescence switch genes p53 and p16INK4a (induced by DNA damage), enabling dormant senescent cells to regain their capacity for division and self-renewal, effectively turning back the clock at the genetic level.
2.2 Reversing SASP (Senescence-Associated Secretory Phenotype) — Cellular “Senomorphics”
In modern anti-aging medicine, clearing or modifying the toxic factors secreted by senescent cells (SASP, e.g., IL-6, IL-8, MMPs) is the most sought-after strategy.
NanoActive® BAICALIN demonstrates potent “Senomorphic” activity. It strongly inhibits the NF-κB inflammatory signaling pathway, severing the contagious cascade of SASP that destroys the surrounding healthy Extracellular Matrix (ECM), thereby protecting the Type I and Type III collagen networks.
2.3 Awakening the Nrf2/ARE Antioxidant Master Switch
Transcending the limitations of traditional antioxidants (like Vitamin C and E) which consume themselves in a 1:1 ratio with free radicals, NanoActive® BAICALIN acts as an “ignition key” for the cell’s endogenous defense mechanisms. By dissociating the Keap1-Nrf2 complex, it promotes Nrf2 nuclear translocation and binding to the ARE sequence, exponentially amplifying the expression of endogenous antioxidant enzymes (SOD, CAT, GSH-Px).
3. Outstanding Scientific Efficacy: Defining Anti-Aging Limits with Data
3.1 Nano-Targeted Delivery & Kinetics
Experiment A: HaCaT Cellular Internalization
Assessed using fluorescent probes (Coumarin-6) combined with flow cytometry and confocal microscopy.
●Results: After a 2-hour incubation, the absolute intracellular fluorescence intensity of the NanoActive® group was 4.2 times higher than that of the unencapsulated free Baicalin group. The biomimetic liposomes seamlessly fused via endocytosis, achieving highly efficient “targeted airdrops.”
Experiment B: Franz Diffusion Cell & Higuchi Release Model
●Penetration: The cumulative amount of Baicalin penetrating the porcine ear epidermis into the receptor fluid over 24 hours was 8.5 times greater for NanoActive® BAICALIN compared to standard Baicalin raw materials.
●Release Profile: The release curve perfectly aligns with the Higuchi Diffusion Equation (R² > 0.98), exhibiting characteristic matrix-type sustained release. It delivers a steady release over 24 hours, avoiding the “peak and valley” effect of drug concentration to ensure long-lasting, gentle, and effective results.
3.2 In Vitro & 3D Ex Vivo Skin Models
Experiment C: Fibroblast Telomerase Activity Protection (TRAP Assay)
Human primary fibroblasts were exposed to a UVA photo-damage model.
●Results: UVA reduced fibroblast telomerase activity to 31.2% of the normal group. Following pretreatment with NanoActive® BAICALIN, telomerase activity recovered to 63.9%, confirming its direct protective effect on the TERT mechanism.
Experiment D: 3D Full-Thickness Skin Model Remodeling
Continuous topical application of the test substance on a reconstructed 3D skin model for 7 days.
●Results: H&E staining and immunofluorescence of tissue sections showed that, compared to the control group, the NanoActive® BAICALIN treated group exhibited a 17% increase in epidermal thickness, a 145% enhancement in the fluorescence expression intensity of Pro-collagen I in the dermis, and a significantly denser and more undulated Dermal-Epidermal Junction (DEJ) architecture.
3.3 In Vivo Clinical Efficacy
●Study Design: A randomized, double-blind, placebo-controlled clinical trial. 35 female subjects aged 35-55 with moderate photoaging and wrinkles applied a base cream containing 2% NanoActive® BAICALIN to half of their face twice daily for 56 days. Instrumental evaluations included VISIA®-CR, Cutometer®, and high-frequency skin ultrasound.
Core Clinical Data:
- Leap in Dermal Density (Skin Density via Ultrasound): Evaluated using a 20 MHz high-frequency ultrasound scan. After 56 days of use, the dermal density significantly increased by 19.3% (measured by the reduction of the Subepidermal Low Echogenic Band, SLEB), proving substantial remodeling of the collagen network.
- Deep Wrinkle Reduction & Smoothing: Maximum depth of crow’s feet wrinkles (Rz) was reduced by 22.4%, and skin roughness (Ra) decreased by 16.5%.
- Potent Soothing & Anti-Inflammaging (Erythema Index): The skin Erythema Index showed a significant drop as early as day 14 (-11%), with a cumulative reduction of 18% over 56 days, clinically validating its soothing efficacy against micro-inflammation induced by SASP.
4. Technical Advantages & Formulation Guidelines
NanoActive® BAICALIN is a “plug-and-play” bioactive designed for high-end skincare products pursuing ultimate clinical efficacy.
- INCI Name: Scutellaria Baicalensis Root Extract
- Appearance: Light yellow to brownish-yellow translucent nano-fluid.
- Particle Size: 10-100nm (DLS detection, PDI < 0.2). This ultra-small particle size is the core of its transparent appearance and deep transdermal penetration.
- Superior Formulation Compatibility:
- Disperses perfectly in the aqueous phase; zero crystallization or precipitation over time.
- Broad pH tolerance range (pH 4.0 – 7.5).
- Ease of Use: Cold processable; can be added directly to the water phase. For hot emulsion systems, addition is recommended during the cooling phase post-homogenization (< 45°C).
●Extreme Stability Challenge: Under accelerated testing for 3 months at 40°C and 5000 Lux illumination, the active retention rate of Baicalin in NanoActive® BAICALIN was> 95%, with zero browning and zero off-odors (Note: unencapsulated Baicalin severely degrades and discolors within 15 days under identical conditions).
Market Positioning & Applications (Claims):
- Recommended Dosage: Daily maintenance and early anti-aging (0.5% – 2.0%); Targeted telomerase activation, intensive anti-wrinkle, and photo-damage repair (2.0% – 5.0%).
- Marketing Claims: Telomerase Guardian, Cellular Longevity Extension, Senolytics/Senomorphics, Photoaging Reversal, Non-Destructive Deep Delivery.
- Applicable Formats: Premium anti-aging creams, gene-repair base serums, high-potency antioxidant sunscreens, post-microneedling/laser wound-healing serums, luxury scalp anti-aging and anti-hair-loss tonics.
NanoActive® BAICALIN— The underlying engine for international cutting-edge cellular skincare.
Researched and Manufactured by PuriPharm. Fusing macromolecular delivery kinetics with systems biomedicine to rewrite time and unlock the secrets of ageless skin.
NanoActive BENZYL URSOLATE
The Next-Generation Dermal Architect: Precision-Delivered Triterpenoid for Profound Skin Rejuvenation
1. Product Overview
In the pursuit of ultimate skin longevity, unlocking the full potential of natural triterpenoids has been a long-standing challenge due to their inherent insolubility and limited skin penetration.
NanoActive BENZYL URSOLATE represents a breakthrough in active ingredient bio-engineering. By synergizing targeted molecular modification (benzyl esterification of ursolic acid) with advanced sub-micron encapsulation technology, we have created a highly bioavailable, potent, and stable anti-aging active. It fundamentally restores Extracellular Matrix (ECM) homeostasis, offering unparalleled firming, anti-wrinkle, and skin-redensifying benefits.
2. The Science: Mechanism of Action
Standard ursolic acid struggles to cross the stratum corneum. NanoActive BENZYL URSOLATE overcomes this through a dual-action optimization strategy:
- Molecular Prodrug Strategy: The attachment of a benzyl group enhances the lipophilicity of the ursolic acid core. Upon penetrating the skin, endogenous epidermal esterases gradually cleave the ester bond, ensuring a sustained and controlled release of the active aglycone directly within the dermal-epidermal junction (DEJ).
- Nanostructured Lipid Delivery: Encapsulated within a phospholipid-based nanocarrier system (< 100 nm), the active is shielded from premature degradation. The biomimetic lipid bilayer structure merges seamlessly with the stratum corneum intercellular lipids, facilitating deep transfollicular and intercellular penetration.
- ECM Remodeling & Pathway Regulation: Once delivered to the fibroblasts, it acts as a robust inhibitor of Matrix Metalloproteinases (specifically MMP-1 and MMP-9) and human leukocyte elastase (HLE). Simultaneously, it upregulates the synthesis of Collagen I, Collagen III, and ceramides, reversing chronological and photo-induced structural degradation.
3. Key Efficacy Highlights
- Profound Wrinkle Reduction: Visibly diminishes the depth and volume of crow’s feet and nasolabial folds by restructuring the dermal fiber network.
- Enhanced Skin Biomechanics: Significantly improves skin elasticity and firmness, combating gravity-induced sagging.
- Barrier Restoration: Stimulates endogenous ceramide production, reinforcing the skin’s natural lipid barrier and reducing Transepidermal Water Loss (TEWL).
- Inflammaging Defense: Exhibits potent anti-inflammatory properties by modulating COX-2 pathways, soothing micro-inflammation that accelerates cellular aging.
4. Technical Data & Formulation Guidelines
Designed with the formulator in mind, NanoActive BENZYL URSOLATE integrates seamlessly into modern cosmetic chassis.
- INCI Name: Water, Glycerin, Caprylic/Capric Triglyceride, Phospholipids, Benzyl Ursolate
- Appearance: Translucent to slightly opalescent fluid.
- Solubility: Water-dispersible (forms stable nano-emulsion).
- Recommended Usage Level: 1.0% – 5.0%
- pH Stability Range: 4.5 – 6.5
- Formulation Advice: Add during the cooling phase (below 45°C) to preserve the integrity of the liposomal structures. Avoid high-shear homogenization after addition. Compatible with most emulsifiers, polymers, and other anti-aging actives (e.g., Peptides, Niacinamide).
5. Ideal Applications
- Intensive Anti-Aging Serums & Ampoules
- Skin Contouring and Firming Creams
- Post-Procedure Barrier Repair Lotions
- Premium Eye Care Formulations
Elevate your formulations with the precision of science. Contact our technical sales team for in-vivo efficacy data, clinical brochures, and sample requests.
PuriActives® Ursolene™ BZ
Precision-Engineered Triterpenoid: The Cornerstone of Deep Dermal Rejuvenation & Structural Reconstruction
The Botanical Bottleneck
Natural pentacyclic triterpenes like Ursolic Acid possess exceptional biological activities, but face severe cosmetic limitations:
Extremely poor lipophilicity restricts formulation versatility.
Low skin penetration limits clinical bioavailability.
High propensity to crystallize destabilizes emulsions.
The Solution: By introducing a benzyl group, we fundamentally shift the molecule’s partition coefficient, creating a highly bioavailable, oil-soluble powerhouse.
Mechanism of Action
Bioavailability Shift
The structural transformation from Ursolic Acid to Ursolene™ BZ is rooted in a fundamental alteration of the lipid-water partition coefficient.
This precise structural modification transforms a traditional botanical extract into a pharmaceutical-grade, oil-soluble active that seamlessly crosses the stratum corneum to reach deep dermal targets.
In Vitro Efficacy
Dermal Architecture Support
Our rigorous efficacy testing matrix demonstrates statistically significant improvements compared to vehicle and unmodified free ursolic acid controls.
Tested on primary human fibroblasts at 10 μM concentration (p < 0.01). The dramatic reduction in UV-induced elastase activity ensures the preservation of the skin’s vital recoil capacity.
In Vivo Clinical Results
A double-blind, placebo-controlled clinical study on 30 female volunteers (aged 45-65), applying a 0.2% PuriActives® Ursolene™ BZ cream twice daily for 28 days.
Stability Comparison
Comparative analysis of formulation stability and lipid solubility scores (measured as a relative percentage of an ideal oil-soluble active profile).
Technical Guidelines
Sustainable Sourcing
Target Applications
The perfect synergy of a naturally derived core and rational structural design, bridging the gap between pharmaceutical-grade precision and cosmetic applicability.
PuriActives® Ursolene™ BZ (Benzyl Ursolate)
Precision-Engineered Triterpenoid: The Cornerstone of Deep Dermal Rejuvenation & Structural Reconstruction
1. Product Overview
While natural pentacyclic triterpenes (like Ursolic Acid) are renowned for their exceptional biological activities, their cosmetic application has historically been bottlenecked by extremely poor lipophilicity, low skin penetration, and formulation instability (propensity to crystallize).
Enter PuriActives® Ursolene™ BZ (INCI: Benzyl Ursolate). By introducing a benzyl group to the ursolic acid backbone, we have fundamentally shifted the molecule’s partition coefficient ( log P). This precise structural modification transforms a traditional botanical extract into a highly bioavailable, oil-soluble powerhouse. It precisely targets the Extracellular Matrix (ECM) architecture, offering a definitive solution for intrinsic/extrinsic aging, loss of elasticity, and compromised skin barriers.
The Core Edge: The perfect synergy of a naturally derived core and rational structural design, bridging the gap between pharmaceutical-grade precision and cosmetic applicability.
2. Key Biological Pathways & Mechanism of Action
PuriActives® Ursolene™ BZ operates through a multi-target mechanism, mitigating tissue senescence at the cellular level:
MMP Modulation & ECM Protection: Acts as a potent competitive inhibitor of Matrix Metalloproteinases (specifically MMP-1 and MMP-9), halting the enzymatic degradation cascade of collagen and elastin networks.
Fibroblast Activation via TGF-β Pathway: Stimulates the transforming growth factor-beta (TGF-β) signaling pathway, upregulating COL1A1 and COL3A1 gene expression to drive the de novo synthesis of structural proteins.
Inflammaging Mitigation: Suppresses the cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) pathways, interrupting the chronic micro-inflammatory cascades that accelerate tissue aging.
Epidermal Lipid Biosynthesis: Upregulates serine palmitoyltransferase (SPT) activity, driving endogenous ceramide production to fortify the stratum corneum barrier.
3. Proven Efficacy (In Vitro & In Vivo Highlights)
Our rigorous efficacy testing matrix demonstrates statistically significant improvements compared to vehicle and unmodified free ursolic acid controls.
In Vitro: Dermal Architecture Support
- + 42% Increase in Pro-collagen I synthesis (Primary human fibroblasts, at 10μM, ).
- – 65% Reduction in UV-induced elastase activity, effectively preserving skin recoil capacity.
In Vivo Clinical Study: Facial Micro-Topography (28-Day Study)
A double-blind, placebo-controlled clinical study on 30 female volunteers (aged 45-65), applying a 0.2% PuriActives® Ursolene™ BZ cream twice daily.
● Wrinkle Depth (Ra): Significant reduction of 21.4% in the periocular region.
● Skin Density: Ultrasound imaging revealed a +15% increase in dermal echogenicity, indicating structural redensification of the dermis.
4. Formulation & Technical Guidelines
PuriActives® Ursolene™ BZ is engineered for the ultimate formulator experience. Its esterified structure completely circumvents the notorious crystallization issues of free ursolic acid, enabling the creation of highly stable, cosmetically elegant emulsions.
● INCI Name: Benzyl Ursolate
● Appearance: White to off-white crystalline powder
● Solubility: Soluble in cosmetic esters (e.g., Caprylic/Capric Triglyceride, Squalane), ethanol, and glycols. Insoluble in water.
● Recommended Usage Level: 0.05% – 0.30%
● Formulation Integration: Add to the heated oil phase ( 70~80℃ ) and stir until fully dissolved before emulsification.
● Optimal pH Range: 4.5 – 6.5
5. Sustainability & Purity
PuriActives® Ursolene™ BZ is derived from upcycled apple pomace and rosemary extract precursors, synthesized via a highly efficient, atom-economical esterification process. We guarantee an ultra-high purity active (HPLC ＞ 95%) while minimizing our environmental footprint.
Recommended Applications:
● Premium Anti-Aging Night Creams
● Intensive Barrier Repair Serums
● Dermo-cosmetics (Post-Procedure Care)
● Sun Recovery & “Anti-Inflammaging” Formulations
NanoActive DHM
NanoActive DHM Epigenetic Youth Restorer & DNA Methylation Inhibitor
1. PRODUCT IDENTIFICATION
- Product Name: NanoActive DHM
- Trade Name: NanoActive DHM by PuriPharm
- INCI Name: Water, Glycerin, Caprylic/Capric Triglyceride, Ampelopsis Grossedentata Extract, Phospholipids, Tocopheryl Acetate.
- Botanical Source of Active: Ampelopsis grossedentata(Vine Tea)
- Active Content: 9.5% – 10.5% (Ampelopsis Grossedentata Extract)
2. PRODUCT DESCRIPTION
NanoActive DHM represents a paradigm shift in epigenetic anti-aging. Developed by PuriPharm Co. Ltd., it is the industry’s first cosmetically viable DNA methylation inhibitor. Utilizing advanced nanoliposomal technology, highly purified Dihydromyricetin (DHM) is encapsulated in a biomimetic phospholipid bilayer. This sophisticated delivery system overcomes the inherent instability and poor skin penetration of DHM, allowing for targeted delivery to the deep epidermis and dermis, fundamentally reversing cellular aging at the genetic transcription level.
3. MECHANISM OF ACTION
Environmental stressors (UV, pollution) and intrinsic aging lead to hypermethylation of DNA, which functionally “silences” essential youth and structural genes.
- Epigenetic Reversal: NanoActive DHM acts as a potent DNA methylation inhibitor, effectively removing age-induced methyl tags.
- Gene Reactivation: By modulating over 10,000 methylation sites, it reactivates silenced genes associated with the Extracellular Matrix (ECM), signal transduction, and autophagy.
- Targeted Delivery: The 50-150 nm liposomal spheres ensure enhanced transdermal absorption and a sustained-release profile, maximizing biological availability and minimizing potential irritation.
4. TECHNICAL SPECIFICATIONS
5. EFFICACY & CLINICAL DATA SUMMARY
- Transcriptomic Upregulation: Significantly upregulates key structural genes including COL6A1 (Collagen Type VI), ITGB6, ITGA5, and VCL, restoring cellular anchorage and tissue firmness.
- 3D Skin Equivalent Model: In a 6-week in vitrostudy utilizing 20µM DHM on mature 3D skin models, NanoActive DHM effectively reversed epidermal thinning. Epidermal thickness increased from 30µm (untreated mature control) to ~50µm, closely mirroring the baseline of young skin models (60µm). Statistical significance achieved (p = 0.00064).
6. FORMULATION GUIDELINES
NanoActive DHM is designed for ease of use in premium cosmetic formulations.
- Recommended Usage Level: 1.0% – 5.0%
- Incorporation Phase: Add to the aqueous phase or during the cooling phase (below 45°C) for emulsions to maintain liposomal integrity.
- pH Compatibility: Stable within a final formulation pH range of 4.5 – 7.5.
- Incompatibilities: Avoid high concentrations of strong ionic surfactants or extreme ethanol levels (>20%) which may disrupt the lipid bilayer.
- Processability: Do not subject to intense, prolonged shear force (homogenization > 3000 rpm for extended periods) after incorporation.
7. TARGET APPLICATIONS
- Premium Anti-Aging Skincare: Serums, night creams, and eye treatments targeting chronological aging and photoaging.
- Medical Aesthetics Post-Care: Restorative formulations designed to prolong the effects of clinical treatments by maintaining epigenetic cellular health.
- Preventative Aging: Solutions targeting millennials/Gen-Z exposed to urban pollution, stress, and lifestyle-induced epigenetic damage.
8. STORAGE & SHELF LIFE
- Storage Conditions: Store in a cool, dry place away from direct sunlight. Recommended storage temperature: 4°C – 25°C. Do not freeze. Keep containers tightly sealed when not in use.
- Shelf Life: 24 months from the date of manufacture under optimal storage conditions.
Disclaimer: The information provided herein is based on our current knowledge and rigorous scientific testing. It is intended for informational purposes for cosmetic professionals and formulators. It is the responsibility of the formulator to ensure the stability, safety, and regulatory compliance of the final consumer product.
PuriPharm Co. Ltd.Pioneering Epigenetic Skincare SolutionsWebsite: www.puriactives.com | Email: service@puripharm.com
